Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Celyad Oncology SA CLYYF

Full chart Compare
Set alert

Price alert · CLYYF

All alert types
0.28 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.315 Day range 0.315
0.15 52-week range 0.35
YTD
+86.67%
1 year
+40.00%

Financial health

Altman Z-Score

-219.69 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 6.6×
FY 2016: -7.0×FY 2017: -5.5×FY 2018: -7.3×FY 2019: -4.4×FY 2020: -5.9×FY 2021: -2.4×FY 2022: -0.1×FY 2023: -1.2×FY 2024: -1.7×FY 2025: 6.6×
FY 2016 5y median -1.2× FY 2025
P/S 260×
FY 2016: 16.6×FY 2017: 87.8×FY 2018: 85.1×FY 2019: 20938×FY 2020: 20875×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 98.5×FY 2024: 52.7×FY 2025: 260×
FY 2016 5y median 52.7× FY 2025
P/B 2.2×
FY 2016: 1.8×FY 2017: 6.5×FY 2018: 4.8×FY 2019: 2.8×FY 2020: 3.4×FY 2021: 1.5×FY 2022: 1.2×FY 2023: 1.6×FY 2024: -0.6×FY 2025: 2.2×
FY 2016 5y median 1.5× FY 2025
P/FCF -0.8×
FY 2016: -6.3×FY 2017: -6.2×FY 2018: -9.1×FY 2019: -4.4×FY 2020: -3.7×FY 2021: -2.4×FY 2022: -0.2×FY 2023: -0.6×FY 2024: -1.7×FY 2025: -0.8×
FY 2016 5y median -0.8× FY 2025
EV/EBITDA -0.5×
FY 2016: -5.4×FY 2017: -5.3×FY 2018: -6.2×FY 2019: -3.4×FY 2020: -6.1×FY 2021: -1.4×FY 2022: 0.2×FY 2023: -0.5×FY 2024: -4.3×FY 2025: -0.5×
FY 2016 5y median -0.5× FY 2025
EV/Sales 179×
FY 2016: 11.9×FY 2017: 81.6×FY 2018: 72.6×FY 2019: 15109×FY 2020: 18156×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 40.2×FY 2024: 124×FY 2025: 179×
FY 2016 5y median 40.2× FY 2025
FCF Yield -126.3%
FY 2016: -16.0%FY 2017: -16.2%FY 2018: -10.9%FY 2019: -22.9%FY 2020: -26.8%FY 2021: -42.4%FY 2022: -533.3%FY 2023: -160.2%FY 2024: -57.9%FY 2025: -126.3%
FY 2016 5y median -126.3% FY 2025

Profitability

Gross Margin 9195.7%
FY 2016: 84.6%FY 2017: 85.5%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 32.4%FY 2024: 93.5%FY 2025: 9195.7%
FY 2016 5y median 32.4% FY 2025
Operating Margin -34201.8%
FY 2016: -255.8%FY 2017: -1493.7%FY 2018: -1225.4%FY 2019: -481316.7%FY 2020: -339740.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -8291.2%FY 2024: -3149.5%FY 2025: -34201.8%
FY 2016 5y median -3149.5% FY 2025
Net Margin 3952.6%
FY 2016: -235.8%FY 2017: -1593.1%FY 2018: -1201.5%FY 2019: -477200.0%FY 2020: -350020.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -8282.4%FY 2024: -3131.2%FY 2025: 3952.6%
FY 2016 5y median 0.0% FY 2025
ROE 34.1%
FY 2016: -26.0%FY 2017: -118.6%FY 2018: -67.3%FY 2019: -62.8%FY 2020: -56.5%FY 2021: -60.8%FY 2022: -948.2%FY 2023: -134.0%FY 2024: 36.1%FY 2025: 34.1%
FY 2016 5y median -60.8% FY 2025
ROIC 366.4%
FY 2016: -20.0%FY 2017: -75.2%FY 2018: -44.7%FY 2019: -36.4%FY 2020: -30.7%FY 2021: -39.4%FY 2022: -433.4%FY 2023: -61.2%FY 2024: -79.5%FY 2025: 366.4%
FY 2016 5y median -61.2% FY 2025
ROA 19.3%
FY 2016: -17.0%FY 2017: -72.6%FY 2018: -39.7%FY 2019: -31.9%FY 2020: -26.5%FY 2021: -33.2%FY 2022: -207.6%FY 2023: -51.9%FY 2024: -58.7%FY 2025: 19.3%
FY 2016 5y median -51.9% FY 2025

Growth (YoY)

Revenue -88.7%
FY 2016: 333633.3%FY 2017: -64.6%FY 2018: -12.0%FY 2019: -99.8%FY 2020: -16.7%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 82.4%FY 2025: -88.7%
FY 2016 FY 2025
Operating Income -22.6%
FY 2016: 13.7%FY 2017: -106.5%FY 2018: 27.8%FY 2019: 24.3%FY 2020: 41.2%FY 2021: -55.4%FY 2022: -54.8%FY 2023: 79.3%FY 2024: 30.7%FY 2025: -22.6%
FY 2016 FY 2025
EPS (diluted) 112.8%
FY 2016: 26.2%FY 2017: -131.6%FY 2018: 44.4%FY 2019: 29.8%FY 2020: 45.0%FY 2021: -34.9%FY 2022: -6.5%FY 2023: 81.8%FY 2024: 57.6%FY 2025: 112.8%
FY 2016 FY 2025
Free Cash Flow -21.4%
FY 2016: 5.9%FY 2017: -90.4%FY 2018: 42.4%FY 2019: 0.7%FY 2020: 2.9%FY 2021: 3.4%FY 2022: -4.1%FY 2023: 42.8%FY 2024: 64.7%FY 2025: -21.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.9×
FY 2016: 7.6×FY 2017: 4.6×FY 2018: 5.4×FY 2019: 3.6×FY 2020: 1.7×FY 2021: 2.5×FY 2022: 1.4×FY 2023: 3.8×FY 2024: 2.3×FY 2025: 1.9×
FY 2016 5y median 2.3× FY 2025
Quick Ratio 1.9×
FY 2016: 7.5×FY 2017: 4.6×FY 2018: 5.4×FY 2019: 3.6×FY 2020: 1.5×FY 2021: 2.5×FY 2022: 1.4×FY 2023: 3.8×FY 2024: 2.1×FY 2025: 1.9×
FY 2016 5y median 2.1× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.2×FY 2024: -1.1×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 2.1×FY 2017: 0.4×FY 2018: 1.1×FY 2019: 1.3×FY 2020: 0.9×FY 2021: 1.1×FY 2022: 0.3×FY 2023: 0.8×FY 2024: -2.5×FY 2025: 0.2×
FY 2016 5y median 0.3× FY 2025
Interest Coverage -112×
FY 2016: -235×FY 2017: -367×FY 2018: -616×FY 2019: -84.2×FY 2020: -39.1×FY 2021: -103×FY 2022: -207×FY 2023: -101×FY 2024: -59.2×FY 2025: -112×
FY 2016 5y median -103× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31